Evidence map›Paper›PMID 32377375›Full record

ArticleCell discovery2020

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.

Wen Wen, Wenru Su, Hao Tang, Wenqing Le, Xiaopeng Zhang, Yingfeng Zheng, Xiuxing Liu, Lihui Xie, Jianmin Li, Jinguo Ye and 8 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Cell discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04438629 (Evaluation of Immune Response in COVID-19 Patients), which is not on this map. Cited by 555 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
555citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04438629 unknown statusnot on this map

Evaluation of Immune Response in COVID-19 Patients

TypeobservationalSponsorAzienda Ospedaliera Universitaria Integrata VeronaRan2020 to 2020Enrolled80ConditionsAllergy and Immunology, Infection ViralArmsCOVID-19 treatment
3 · Its place in the literature

Who cites it

555 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Single-cell RNA sequencing offers novel perspectives in viral infection research.Frontiers in cellular and infection microbiology · 2026
    Pooled it
  2. Trial
  3. Trial
  4. VDJ-REMIX: REpertoire Module Identification and eXploration.Bioinformatics (Oxford, England) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Impact of nutrition on long COVID.Sports medicine and health science · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

495 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Wen Wen *1National Center for Liver Cancer, Second Military Medical University, 200438 Shanghai, China.
Wenru Su *2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 510060 Guangzhou, China.
Hao Tang *3Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Second Military Medical University, 200003 Shanghai, China.
Wenqing Le *Department of Critical Care, Wuhan Hankou Hospital, 430000 Wuhan, Hubei China.
Xiaopeng Zhang *6Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, 100071 Beijing, China.
Yingfeng Zheng *2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 510060 Guangzhou, China.
Xiuxing Liu2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 510060 Guangzhou, China.
Lihui Xie2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 510060 Guangzhou, China.
Jianmin Li6Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, 100071 Beijing, China.
Jinguo Ye2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 510060 Guangzhou, China.
Liwei Dong1National Center for Liver Cancer, Second Military Medical University, 200438 Shanghai, China.
Xiuliang Cui1National Center for Liver Cancer, Second Military Medical University, 200438 Shanghai, China.
Yushan Miao3Department of Respiratory and Critical Care Medicine, Changzheng Hospital, Second Military Medical University, 200003 Shanghai, China.
Depeng WangGrandOmics Diagnosis Co. Ltd., 430014 Wuhan, Hubei China.
Jiantao DongBerry Genomics Co. Ltd., 102206 Beijing, China.
Chuanle Xiao2State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 510060 Guangzhou, China.
Wei Chen6Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, 100071 Beijing, China.
Hongyang Wang1National Center for Liver Cancer, Second Military Medical University, 200438 Shanghai, China.

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2018ZX09101002, 2017ZX100203205National Natural Science Foundation of China (National Science Foundation of China) 81530028,81721003National Natural Science Foundation of China (National Science Foundation of China) 81670015National Natural Science Foundation of China (National Science Foundation of China) 81722034National Natural Science Foundation of China (National Science Foundation of China) 81830054, 81988101,91859205Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2016A030306006Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2020B1515020057Shanghai Municipal Human Resources and Social Security Bureau 2019PJD059
6 · The paper itself

Abstract

COVID-19, caused by SARS-CoV-2, has recently affected over 1,200,000 people and killed more than 60,000. The key immune cell subsets change and their states during the course of COVID-19 remain unclear. We sought to comprehensively characterize the transcriptional changes in peripheral blood mononuclear cells during the recovery stage of COVID-19 by single-cell RNA sequencing technique. It was found that T cells decreased remarkably, whereas monocytes increased in patients in the early recovery stage (ERS) of COVID-19. There was an increased ratio of classical CD14

Indexed as

ImmunologyMechanisms of disease

Identifiers

PMID32377375
PMCPMC7197635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.